Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding - 07/09/18
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 7 |
| Iconographies | 2 |
| Vidéos | 0 |
| Autres | 0 |
Summary |
Background |
Hepatic encephalopathy (HE) is a neuropsychiatric complication of decompensated cirrhosis. Proton pump inhibitors (PPIs), used as potent acid suppressants, are associated with HE occurrence in cirrhotic patients. However, it is still unknown if PPIs contribute to mortality in cirrhotic patients with HE and no active gastrointestinal bleeding.
Methods |
We used the Taiwan National Health Insurance Database to identify 1004 cirrhotic patients with HE and no active gastric bleeding, who received oral PPIs between January 1, 2010 and December 31, 2013. On the basis of comorbid disorder data, we used propensity score matching at a 1:4 ratio to select 4016 cirrhotic patients with HE and no active gastric bleeding who did not receive PPIs as a comparison group. All patients were followed up for one year from the index time.
Results |
The overall 30-day, 90-day, and 1-year mortalities were 36.1%, 52.6%, and 70.1% in PPI group, and 27.5%, 41.7%, and 62.4% in non-PPI group. Using Cox regression model analysis with adjustment for age, gender, and other comorbid disorders, we obtained hazard ratios of 1.360 (95% CI: 1.208–1.532, P<0.001), 1.563 (95% CI: 1.314–1.859; P<0.001), and 1.187 (95% CI: 1.008–1.398; P=0.040) for, respectively, 30-day, 30-day to 90-day, and 90-day to 1-year mortality in patients taking PPIs.
Conclusion |
PPIs increase short-term and long-term mortality of cirrhotic patients with HE and no active gastrointestinal bleeding.
Le texte complet de cet article est disponible en PDF.Keywords : Cirrhosis, Hepatic encephalopathy, Proton pump inhibitor, Mortality
Plan
Vol 42 - N° 4
P. 353-359 - septembre 2018 Retour au numéro
Article précédent
- Preoperative erythropoietin treatment improves survival following major hepatic resection in a cirrhotic rat model
- Suk-Won Suh, Yoo Shin Choi, Soon Auck Hong, Hyun Kang, Donghyun Lee, Hye Ryoun Kim
- Helicobacter pylori infection aggravates diet-induced nonalcoholic fatty liver in mice
- Cong He, Dandan Cheng, Huan Wang, Ketao Wu, Yin Zhu, Nonghua Lu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?